143 related articles for article (PubMed ID: 10616523)
41. Identification of TRIB1 R107L gain-of-function mutation in human acute megakaryocytic leukemia.
Yokoyama T; Toki T; Aoki Y; Kanezaki R; Park MJ; Kanno Y; Takahara T; Yamazaki Y; Ito E; Hayashi Y; Nakamura T
Blood; 2012 Mar; 119(11):2608-11. PubMed ID: 22294728
[TBL] [Abstract][Full Text] [Related]
42. [Megakaryocytic leukemia with thrombocytosis].
Nakajima M; Fukunaga H; Amano M; Fukuda T; Ryo R
Rinsho Ketsueki; 1989 Jul; 30(7):1084-8. PubMed ID: 2810795
[TBL] [Abstract][Full Text] [Related]
43. [Infant leukemia with t(1;22) presenting proliferation of erythroid and megakaryocytic cell lineages].
Oshima M; Fukushima T; Koike K; Hoshida C; Izumi I; Tsuchida M
Rinsho Ketsueki; 1999 Mar; 40(3):230-5. PubMed ID: 10222631
[TBL] [Abstract][Full Text] [Related]
44. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T
Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816
[TBL] [Abstract][Full Text] [Related]
45. Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia.
Maitta RW; Wolgast LR; Wang Q; Zhang H; Bhattacharyya P; Gong JZ; Sunkara J; Albanese JM; Pizzolo JG; Cannizzaro LA; Ramesh KH; Ratech H
Am J Hematol; 2011 Feb; 86(2):230-4. PubMed ID: 21264917
[TBL] [Abstract][Full Text] [Related]
46. [Acute megakaryoblastic leukemia in Down's syndrome following refractory anemia with excess of blasts].
Hayashi Y; Habu Y; Fujii Y; Hanada R; Yamamoto K; Nishida T; Eguchi M
Rinsho Ketsueki; 1986 Sep; 27(9):1650-5. PubMed ID: 2949094
[No Abstract] [Full Text] [Related]
47. Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome.
Lightfoot J; Hitzler JK; Zipursky A; Albert M; Macgregor PF
Leukemia; 2004 Oct; 18(10):1617-23. PubMed ID: 15343346
[TBL] [Abstract][Full Text] [Related]
48. Cytogenetic findings in adult acute leukemia and myeloproliferative disorders with an involvement of megakaryocyte lineage.
Ohyashiki K; Ohyashiki JH; Hojo H; Ohtaka M; Toyama K; Sugita K; Nakazawa S; Sugiura K; Nakazawa K; Nagasawa T
Cancer; 1990 Feb; 65(4):940-8. PubMed ID: 2297663
[TBL] [Abstract][Full Text] [Related]
49. Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia.
Rosenthal NS; Farhi DC
Am J Clin Pathol; 1991 Apr; 95(4):556-60. PubMed ID: 2014782
[TBL] [Abstract][Full Text] [Related]
50. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
51. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
[TBL] [Abstract][Full Text] [Related]
52. [The role of GATA1 mutation in acute megakaryocytic leukemia].
Ito E
Rinsho Ketsueki; 2006 Nov; 47(11):1415-22. PubMed ID: 17176883
[No Abstract] [Full Text] [Related]
53. Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
[TBL] [Abstract][Full Text] [Related]
54. Characteristics of megakaryocyte progenitors in megakaryoblastic leukemia.
Mizoguchi H; Katahira J; Akahoshi M
Keio J Med; 1987 Jan; 36(1):83-5. PubMed ID: 3475497
[No Abstract] [Full Text] [Related]
55. Acute megakaryoblastic leukaemia in a child.
Russo F; Buda F; Buda C; Aragona P; Tessitori G; Simon G; Chillemi S; Caristi N; Faiella A
Eur J Cancer; 1991; 27(12):1713-4. PubMed ID: 1782091
[No Abstract] [Full Text] [Related]
56. Acute T lymphoid and megakaryoblastic bi-lineal leukemia in a child.
Srinivas U; Saxena R; Bakhshi S
Indian Pediatr; 2007 Jul; 44(7):541-3. PubMed ID: 17684307
[TBL] [Abstract][Full Text] [Related]
57. Cloning and characterization of the novel chimeric gene p53/FXR2 in the acute megakaryoblastic leukemia cell line CMK11-5.
Kanezaki R; Toki T; Xu G; Narayanan R; Ito E
Tohoku J Exp Med; 2006 Jul; 209(3):169-80. PubMed ID: 16778363
[TBL] [Abstract][Full Text] [Related]
58. Expression of erythroid-specific genes in megakaryoblastic disorders.
Ito E; Kasai M; Toki T; Arai K; Yokoyama M
Leuk Lymphoma; 1996 Nov; 23(5-6):545-50. PubMed ID: 9031085
[TBL] [Abstract][Full Text] [Related]
59. Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression.
Matsuo H; Wakita T; Hiramatsu H; Ohmori K; Kodama K; Nakatani K; Kamikubo Y; Iwamoto S; Kondo T; Takaori-Kondo A; Takita J; Tomizawa D; Taga T; Adachi S
Br J Haematol; 2021 Jan; 192(1):e7-e11. PubMed ID: 33095915
[No Abstract] [Full Text] [Related]
60. Molecular insights into Down syndrome-associated leukemia.
Vyas P; Crispino JD
Curr Opin Pediatr; 2007 Feb; 19(1):9-14. PubMed ID: 17224656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
